NARECHEM-ST Clinical Data/Follow-up

  • Second primary tumours preceding or following current disease are provided in collaboration with treating physicians
    • Clinical and follow-up outcome data, including relapses, bone marrow transplantation and survival of registered patients are provided by the treating physicians on an annual basis
      • Long-term follow-up of all registered patients (late effects, second malignancies, survival) is conducted and needs to be further systematized